Brokerages Set Crescent Capital BDC, Inc. (NASDAQ:CCAP) Target Price at $19.33

Crescent Capital BDC, Inc. (NASDAQ:CCAP) has received an average recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $19.33.

CCAP has been the subject of several research reports. Keefe, Bruyette & Woods lifted their price objective on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research note on Monday, November 25th. Wells Fargo & Company lifted their price target on Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Wednesday, January 29th.

Institutional Trading of Crescent Capital BDC

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Montag A & Associates Inc. acquired a new stake in shares of Crescent Capital BDC during the 4th quarter valued at about $35,000. Point72 Asset Management L.P. purchased a new position in Crescent Capital BDC during the second quarter worth approximately $90,000. Cubist Systematic Strategies LLC acquired a new stake in Crescent Capital BDC in the second quarter valued at approximately $346,000. Ieq Capital LLC increased its position in shares of Crescent Capital BDC by 2.6% in the fourth quarter. Ieq Capital LLC now owns 22,725 shares of the company’s stock valued at $437,000 after buying an additional 584 shares in the last quarter. Finally, Pettinga Financial Advisors LLC raised its stake in shares of Crescent Capital BDC by 95.8% during the 3rd quarter. Pettinga Financial Advisors LLC now owns 29,017 shares of the company’s stock worth $537,000 after buying an additional 14,200 shares during the period. Institutional investors and hedge funds own 49.46% of the company’s stock.

Crescent Capital BDC Stock Performance

Shares of Crescent Capital BDC stock opened at $19.53 on Friday. The company has a market capitalization of $723.78 million, a PE ratio of 7.66 and a beta of 0.81. The company has a 50-day simple moving average of $19.40 and a two-hundred day simple moving average of $18.77. Crescent Capital BDC has a one year low of $15.91 and a one year high of $20.03. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.26 and a current ratio of 1.26.

Crescent Capital BDC (NASDAQ:CCAP) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.57 by $0.07. The firm had revenue of $51.63 million during the quarter, compared to analyst estimates of $48.76 million. Crescent Capital BDC had a net margin of 47.06% and a return on equity of 12.20%. During the same period last year, the firm posted $0.59 EPS. Research analysts expect that Crescent Capital BDC will post 2.43 EPS for the current fiscal year.

Crescent Capital BDC Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st were paid a $0.42 dividend. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.07. The ex-dividend date was Tuesday, December 31st. This represents a $1.68 dividend on an annualized basis and a dividend yield of 8.60%. Crescent Capital BDC’s dividend payout ratio is presently 65.88%.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.